Leveraging pre-vaccination antibody titres across multiple influenza H3N2 variants to forecast the post-vaccination response.
- DOI
- 10.1016/j.ebiom.2025.105744
- Published
- 2025 Jun
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2025.105744,
title = {Leveraging pre-vaccination antibody titres across multiple influenza H3N2 variants to forecast the post-vaccination response.},
author = {Stacey H and Carlock MA and Allen JD and Hanley HB and Crotty S and Ross TM and Einav T},
year = {2025},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2025.105744},
url = {https://doi.org/10.1016/j.ebiom.2025.105744}
}RIS
TY - JOUR TI - Leveraging pre-vaccination antibody titres across multiple influenza H3N2 variants to forecast the post-vaccination response. AU - Stacey H AU - Carlock MA AU - Allen JD AU - Hanley HB AU - Crotty S AU - Ross TM AU - Einav T PY - 2025 JO - EBioMedicine DO - 10.1016/j.ebiom.2025.105744 UR - https://doi.org/10.1016/j.ebiom.2025.105744 ER -
APA
H, S., MA, C., JD, A., HB, H., S, C., TM, R., & T, E. (2025). Leveraging pre-vaccination antibody titres across multiple influenza H3N2 variants to forecast the post-vaccination response.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2025.105744
Source records
- pubmed · retrieved 2026-11-10T19:14:11.033Z